Literature DB >> 35018554

Assessment of Pharmacokinetic Parameters of Daidzein-Containing Nanosuspension and Nanoemulsion Formulations After Oral Administration to Rats.

Esra Demirtürk1, Afife Büşra Ugur Kaplan2, Meltem Cetin2, Kübra Akıllıoğlu3, Meltem Dönmez Kutlu3, Seda Köse3, Fazilet Aksu4.   

Abstract

BACKGROUND AND OBJECTIVES: Daidzein has several biological effects such as antioxidation, anti-inflammation, chemoprevention, and anticancer effects. The aim of this study was to evaluate the impact of nano-formulations (nanoemulsion-NE and nanosuspension-NS) prepared to increase the oral bioavailability of daidzein, a poorly water-soluble isoflavone, on the pharmacokinetic parameters of daidzein in rats.
METHODS: A high-performance liquid chromatography-ultraviolet (HPLC-UV) method was successfully developed for daidzein analysis in rat plasma. The pharmacokinetics studies of the nano-sized formulations, compared to coarse daidzein suspension, were carried out in the rats by a single oral dose at 10 mg/kg (n = 6/group). Area under the plasma concentration-time curve from time zero to extrapolation to time infinity (AUC0-∞), maximum plasma concentration (Cmax), time to reach maximum plasma concentration (tmax), and elimination half life (t1/2) values for coarse daidzein suspension, daidzein-NS, and daidzein-NE were estimated by a non-compartmental analysis.
RESULTS: The AUC values of daidzein-NE and daidzein-NS were approximately 2.62 and 2.65 times higher than that of coarse daidzein suspension, respectively (p < 0.05). Relative bioavailability (Frel) (%) values of daidzein following oral administration of nanosuspension or nanoemulsion formulations were about 265.6% and 262.3%, respectively.
CONCLUSION: It revealed that nanoscale size is an important factor to overcome any dissolution rate barriers to oral bioavailability of the low water-soluble compound. Nanoemulsion and nanosuspension formulations are beneficial dosage forms to increase the oral bioavailability of Biopharmaceutical Classification System (BCS) Class II and Class IV compounds.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35018554     DOI: 10.1007/s13318-021-00746-5

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.

Authors:  Samira Khani; Fariborz Keyhanfar; Amir Amani
Journal:  Drug Deliv       Date:  2015-09-25       Impact factor: 6.419

2.  Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.

Authors:  Chen Zhao; Yitong Wang; Yunzhang Su; Hongfeng Zhang; Lingxiao Ding; Xiaofeng Yan; Di Zhao; Naimin Shao; Xiyun Ye; Yiyun Cheng
Journal:  Int J Pharm       Date:  2011-10-04       Impact factor: 5.875

3.  Development and validation of an HPLC method for determination of rofecoxib in bovine serum albumin microspheres.

Authors:  Esra DemİrtÜrk; Emirhan Nemutlu; Selma Şahİn; Levent Öner
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

Review 4.  Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids.

Authors:  G Leonarduzzi; G Testa; B Sottero; P Gamba; G Poli
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.

Authors:  Hui Wang; Yi Xiao; Hai Wang; Zechun Sang; Xiaole Han; Shuzhen Ren; Ruofei Du; Xiufeng Shi; Yan Xie
Journal:  Int J Pharm       Date:  2019-05-21       Impact factor: 5.875

6.  Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro.

Authors:  Anne Christiansen; Thomas Backensfeld; Karsten Denner; Werner Weitschies
Journal:  Eur J Pharm Biopharm       Date:  2011-01-08       Impact factor: 5.571

7.  Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids.

Authors:  Joseph A Rothwell; Andrea J Day; Michael R A Morgan
Journal:  J Agric Food Chem       Date:  2005-06-01       Impact factor: 5.279

8.  Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.

Authors:  Hongjian Zhang; Ming Yao; Richard A Morrison; Saeho Chong
Journal:  Arch Pharm Res       Date:  2003-09       Impact factor: 4.946

9.  Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.

Authors:  Mayank Kumar Singh; Deep Pooja; Halley Gora Ravuri; Anusha Gunukula; Hitesh Kulhari; Ramakrishna Sistla
Journal:  Phytomedicine       Date:  2017-12-20       Impact factor: 5.340

10.  Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes.

Authors:  Qiao Wang; Wenjin Liu; Junjun Wang; Hong Liu; Yong Chen
Journal:  Nanoscale Res Lett       Date:  2019-10-15       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.